Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022 16:05 ET
|
Cytek Biosciences, Inc.
Third quarter revenue grew 18% compared to prior year quarter Improved gross margins, net income, and adjusted EBITDA over prior year quarter FREMONT, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ...
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 16:30 ET
|
Cytek Biosciences, Inc.
Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today...
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter...
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
October 26, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 31st...
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
August 30, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 20th...
Cytek Biosciences Reports Second Quarter 2022 Financial Results
August 10, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30,...
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference
July 21, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating in the upcoming 42nd...
Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022
July 20, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter...
Cytek Biosciences to Host Inaugural Analyst and Investor Day
June 01, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) announced today that it will host its inaugural Analyst and Investor Day...
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
May 24, 2022 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc....